ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Long-term correction of rat model of Parkinson's disease by gene therapy
Nature
◽
10.1038/362450a0
◽
1993
◽
Vol 362
(6419)
◽
pp. 450-453
◽
Cited By ~ 163
Author(s):
Shoushu Jiao
◽
Vladimir Gurevich
◽
Jon A. Wolff
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Rat Model
Download Full-text
Related Documents
Cited By
References
Erratum: Long-term correction of rat model of Parkinson's disease by gene therapy
Nature
◽
10.1038/380734a0
◽
1996
◽
Vol 380
(6576)
◽
pp. 734-734
◽
Cited By ~ 3
Author(s):
Shoushu Jiao
◽
Vladimir Gurevich
◽
Jon A. Wolff
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Rat Model
Download Full-text
Faculty Opinions recommendation of Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.727492597.793530605
◽
2017
◽
Author(s):
Laurent Villard
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Gene Therapy Trial
◽
Long Term Follow Up
◽
Therapy Trial
Download Full-text
1041 Parkin gene therapy for alpha synucleinopathy: A rat model of Parkinson's disease
Journal of the Neurological Sciences
◽
10.1016/s0022-510x(05)81406-6
◽
2005
◽
Vol 238
◽
pp. S364
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Rat Model
◽
Parkin Gene
Download Full-text
1051. A Fail-Safe System for Gene Therapy of Parkinson's Disease; Application of Removable Expression Cassette To Prevent Overproduction of Dopamine in a Rat Model
Molecular Therapy
◽
10.1016/j.ymthe.2004.06.996
◽
2004
◽
Vol 9
◽
pp. S403
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Rat Model
◽
Expression Cassette
◽
Fail Safe
Download Full-text
Long-Term Survival of Human Central Nervous System Progenitor Cells Transplanted into a Rat Model of Parkinson's Disease
Experimental Neurology
◽
10.1006/exnr.1997.6634
◽
1997
◽
Vol 148
(1)
◽
pp. 135-146
◽
Cited By ~ 321
Author(s):
Clive N. Svendsen
◽
Maeve A. Caldwell
◽
Jinkun Shen
◽
Melanie G. ter Borg
◽
Anne E. Rosser
◽
...
Keyword(s):
Parkinson’S Disease
◽
Central Nervous System
◽
Parkinson's Disease
◽
Nervous System
◽
Progenitor Cells
◽
Rat Model
◽
Human Central Nervous System
◽
Term Survival
◽
Long Term Survival
Download Full-text
Pattern of long-term sensorimotor recovery following intrastriatal and -accumbens DA micrografts in a rat model of Parkinson's disease
The Journal of Comparative Neurology
◽
10.1002/cne.22035
◽
2009
◽
Vol 515
(1)
◽
pp. 41-55
◽
Cited By ~ 13
Author(s):
Gero Falkenstein
◽
Christoph Rosenthal
◽
Torsten Reum
◽
Rudolf Morgenstern
◽
Máté Döbrössy
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Rat Model
◽
Sensorimotor Recovery
Download Full-text
Parkin Gene Therapy for α-Synucleinopathy: A Rat Model of Parkinson's Disease
Human Gene Therapy
◽
10.1089/hum.2005.16.262
◽
2005
◽
Vol 16
(2)
◽
pp. 262-270
◽
Cited By ~ 84
Author(s):
Masanori Yamada
◽
Yoshikuni Mizuno
◽
Hideki Mochizuki
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Rat Model
◽
Parkin Gene
Download Full-text
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
The Lancet
◽
10.1016/s0140-6736(13)61939-x
◽
2014
◽
Vol 383
(9923)
◽
pp. 1138-1146
◽
Cited By ~ 247
Author(s):
Stéphane Palfi
◽
Jean Marc Gurruchaga
◽
G Scott Ralph
◽
Helene Lepetit
◽
Sonia Lavisse
◽
...
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Dose Escalation
◽
Lentiviral Vector
◽
Phase 1
◽
Open Label
◽
Open Label Phase
Download Full-text
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson’s disease
JCI Insight
◽
10.1172/jci.insight.90133
◽
2017
◽
Vol 2
(7)
◽
Cited By ~ 35
Author(s):
Martin Niethammer
◽
Chris C. Tang
◽
Peter A. LeWitt
◽
Ali R. Rezai
◽
Maureen A. Leehey
◽
...
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Gene Therapy Trial
◽
Long Term Follow Up
◽
Therapy Trial
Download Full-text
Faculty Opinions recommendation of Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718235629.793491568
◽
2014
◽
Author(s):
Joseph Jankovic
◽
Mary Ann Thenganatt
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Dose Escalation
◽
Lentiviral Vector
◽
Phase 1
◽
Open Label
◽
Open Label Phase
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close